Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mavacoxib 是口服长效环氧合酶 2 选择性抑制剂,是长效的非甾体类抗炎药,用于犬退化性关节病相关的炎疼及痛症的研究。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 319 | 现货 | ||
5 mg | ¥ 497 | 现货 | ||
10 mg | ¥ 788 | 现货 | ||
25 mg | ¥ 1,490 | 现货 | ||
50 mg | ¥ 2,320 | 现货 | ||
100 mg | ¥ 3,460 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 547 | 现货 |
产品描述 | Mavacoxib is a selective inhibitor of cyclooxygenase-2 (COX-2) ,with Anti-Tumour activity. |
体外活性 | Mavacoxib is cytotoxic to a panel of human and canine osteosarcoma, mammary and bladder carcinoma cancer cell lines;?that it can induce apoptosis and inhibit the migration of these cells.?Mavacoxib can exert these effects independently of elevated COX-2 expression[1].Mavacoxib has a direct cell killing effect on cancer cells, increases apoptosis in cancer cells in a manner that may be independent of caspase activity, and has an inhibitory effect on cell migration.?Importantly, that cancer stem cells derived from osteosarcoma cell lines are sensitive to the cytotoxic effect of mavacoxib[2] |
分子量 | 385.34 |
分子式 | C16H11F4N3O2S |
CAS No. | 170569-88-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (58.39 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5951 mL | 12.9756 mL | 25.9511 mL | 64.8778 mL |
5 mM | 0.519 mL | 2.5951 mL | 5.1902 mL | 12.9756 mL | |
10 mM | 0.2595 mL | 1.2976 mL | 2.5951 mL | 6.4878 mL | |
20 mM | 0.1298 mL | 0.6488 mL | 1.2976 mL | 3.2439 mL | |
50 mM | 0.0519 mL | 0.2595 mL | 0.519 mL | 1.2976 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Mavacoxib 170569-88-7 Immunology/Inflammation Neuroscience COX Cyclooxygenase Inhibitor inhibit inhibitor